Standard Chemical & Pharmaceutical Co Ltd (1720) - Total Assets
Based on the latest financial reports, Standard Chemical & Pharmaceutical Co Ltd (1720) holds total assets worth NT$11.62 Billion TWD (≈ $366.20 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Standard Chemical & Pharmaceutical Co Lt cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Standard Chemical & Pharmaceutical Co Ltd - Total Assets Trend (2002–2024)
This chart illustrates how Standard Chemical & Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. Explore long-term investment intensity of Standard Chemical & Pharmaceutical Co Lt to see how much of total assets are deployed in long-term investments.
Standard Chemical & Pharmaceutical Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Standard Chemical & Pharmaceutical Co Ltd's total assets of NT$11.62 Billion consist of 44.8% current assets and 55.2% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 13.6% |
| Accounts Receivable | NT$1.34 Billion | 12.0% |
| Inventory | NT$1.72 Billion | 15.4% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$33.82 Million | 0.3% |
| Goodwill | NT$173.91 Million | 1.6% |
Asset Composition Trend (2002–2024)
This chart illustrates how Standard Chemical & Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Standard Chemical & Pharmaceutical Co Lt stock valuation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Standard Chemical & Pharmaceutical Co Ltd's current assets represent 44.8% of total assets in 2024, an increase from 0.0% in 2002.
- Cash Position: Cash and equivalents constituted 13.6% of total assets in 2024, up from 5.4% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2002.
- Asset Diversification: The largest asset category is inventory at 15.4% of total assets.
Standard Chemical & Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of Standard Chemical & Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521
|
China | CN¥22.22 Billion |
|
Bausch Health Companies Inc
TO:BHC
|
Canada | CA$24.50 Billion |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
|
China | CN¥4.44 Billion |
|
Curaleaf Holdings Inc.
TO:CURA
|
Canada | CA$2.88 Billion |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
|
China | CN¥19.57 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
China Animal Husbandry Industry Co Ltd
SHG:600195
|
China | CN¥9.32 Billion |
Standard Chemical & Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.41 | 2.90 | 2.18 |
| Quick Ratio | 1.69 | 1.93 | 1.64 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$3.12 Billion | NT$3.20 Billion | NT$1.95 Billion |
Standard Chemical & Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Standard Chemical & Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.82 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | -0.1% |
| Total Assets | NT$11.18 Billion |
| Market Capitalization | $356.37 Million USD |
Valuation Analysis
Below Book Valuation: The market values Standard Chemical & Pharmaceutical Co Ltd's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Standard Chemical & Pharmaceutical Co Ltd's assets decreased by 0.1% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Standard Chemical & Pharmaceutical Co Ltd (2002–2024)
The table below shows the annual total assets of Standard Chemical & Pharmaceutical Co Ltd from 2002 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | NT$11.18 Billion ≈ $352.09 Million |
-0.12% |
| 2023-12-31 | NT$11.19 Billion ≈ $352.51 Million |
+2.01% |
| 2022-12-31 | NT$10.97 Billion ≈ $345.56 Million |
+8.55% |
| 2021-12-31 | NT$10.10 Billion ≈ $318.33 Million |
+43.33% |
| 2020-12-31 | NT$7.05 Billion ≈ $222.10 Million |
+1.75% |
| 2019-12-31 | NT$6.93 Billion ≈ $218.27 Million |
+7.59% |
| 2018-12-31 | NT$6.44 Billion ≈ $202.87 Million |
+1.02% |
| 2017-12-31 | NT$6.37 Billion ≈ $200.82 Million |
+2.38% |
| 2016-12-31 | NT$6.23 Billion ≈ $196.15 Million |
+7.43% |
| 2015-12-31 | NT$5.80 Billion ≈ $182.58 Million |
+7.83% |
| 2014-12-31 | NT$5.37 Billion ≈ $169.33 Million |
+0.40% |
| 2013-12-31 | NT$5.35 Billion ≈ $168.65 Million |
+4.49% |
| 2012-12-31 | NT$5.12 Billion ≈ $161.41 Million |
+5.29% |
| 2011-12-31 | NT$4.87 Billion ≈ $153.31 Million |
+7.67% |
| 2010-12-31 | NT$4.52 Billion ≈ $142.39 Million |
+17.57% |
| 2009-12-31 | NT$3.84 Billion ≈ $121.11 Million |
+8.34% |
| 2008-12-31 | NT$3.55 Billion ≈ $111.79 Million |
+7.36% |
| 2007-12-31 | NT$3.31 Billion ≈ $104.13 Million |
-5.25% |
| 2006-12-31 | NT$3.49 Billion ≈ $109.89 Million |
+1.65% |
| 2005-12-31 | NT$3.43 Billion ≈ $108.11 Million |
+1.01% |
| 2004-12-31 | NT$3.40 Billion ≈ $107.03 Million |
+3.54% |
| 2003-12-31 | NT$3.28 Billion ≈ $103.37 Million |
+15.06% |
| 2002-12-31 | NT$2.85 Billion ≈ $89.84 Million |
-- |
About Standard Chemical & Pharmaceutical Co Ltd
Standard Chemical & Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese and western medicine, cosmetics, beverage, normal instruments, and medical instruments. It also sells various medical supplements, as well as preventive medicine; and imports and exports various medical products, med… Read more